VANCOUVER, British Columbia, Dec. 30, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), advises that Immunitor has published data from the first half of the 120-patient imm01 clinical ...
Immunitor Company announces presentation of a paper ‘Mucosal AIDS vaccines’ at the 3rd Virtual HIV/AIDS Congress which started on internet on October 14, 2002 and closed on World AIDS day on December ...
NEW YORK, NY / ACCESSWIRE / November 24, 2020 / KEY CAPITAL CORPORATION (OTC PINK:KCPC) advises that Key Biotec, a division of Key Capital, has entered into agreement with Immunitor group interests ...
The Immunitor study is published in January issue of Hepatoma Research (ClinicalTrials.gov Identifier: NCT02232490). "What makes this investigation standing apart from current immunotherapeutic ...
College Park, MD (MMD Newswire) November 26, 2010 -- Immunitor USA Inc., the industry leader in tableted oral vaccines and immunotherapies, has been issued a key patent by the U.S. Patent and ...
Dec. 13, 2010, 3:17 PM UTC / Source: GlobeNewswire VANCOUVER, British Columbia, Dec. 13, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), advises that Immunitor has concluded a ...
SCOTTSDALE, AZ--(Marketwired - Apr 27, 2017) - KEY CAPITAL CORPORATION (OTC PINK: KCPC) advises that in an open-label Phase II study of Hepko-V5 oral immunotherapeutic vaccine conducted in 75 patients ...
NEW YORK, NY / ACCESSWIRE / November 24, 2020 / KEY CAPITAL CORPORATION (OTC PINK:KCPC) advises that Key Biotec, a division of Key Capital, has entered into agreement with Immunitor group interests ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results